At Checkmate Pharmaceuticals, we believe that every person living with cancer should have the best odds for better outcomes.
Our clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. Based on decades of experience pioneering Toll-like receptor (TLR) therapies, we are demonstrating the power and the potential of activating the immune system to improve cancer care and patient outcomes.
Checkmate Pharmaceuticals is a team of scientists, physicians and life sciences entrepreneurs discovering and developing new approaches to fighting cancer. Together, we’re striving to checkmate cancer.